Mani (MNICF) Stock Based Compensation: $0.0 Mil (TTM As of Feb. 2026)


MNICF Mani Inc MNICF
97 GF Score
Price $12.82
GF Value $15.57
! 7 Warning Signs
View Full Analysis

What is Mani Stock Based Compensation?

Mani MNICF 97 Stock Based Compensation is $0.0 Mil as of Feb. 2026. GuruFocus rates MNICF with a GF Score™ of 97/100 and a GF Value™ of $15.57. The stock has 7 warning signs investors should review.

Mani's Stock Based Compensation for the three months ended in Feb. 2026 was $0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2026 was $0.0 Mil.

Mani Stock Based Compensation Related Terms

Mani Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Mani's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mani Stock Based Compensation Chart

Mani Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Mani Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MNICF
97GF Score
Mani Inc MNICF
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mani Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

What does a Stock Based Compensation of $0.0 Mil mean?
Mani (MNICF) has a Stock Based Compensation of $0.0 Mil as of Feb. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Mani and its competitors.
Is Mani's Stock Based Compensation too high?
Mani's current Stock Based Compensation is $0.0 Mil. Overall, Mani has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Mani's Stock Based Compensation compare to ISRG and BDX?
Mani's Stock Based Compensation of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Mani and its competitors. Mani's current Stock Based Compensation is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mani stock overvalued right now?
Mani (MNICF) has a current Stock Based Compensation of $0.0 Mil. The stock's GF Value™ is $15.57, compared to a current price of $12.82 — trading 17.7% below its estimated fair value. The current Stock Based Compensation is $0.0 Mil. Mani's overall GF Score™ is 97/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Mani (MNICF), the current Stock Based Compensation is $0.0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mani (MNICF) Overvalued in 2026?

Based on GuruFocus' analysis, Mani stock appears to be undervalued. The current stock price of $12.82 is trading 17.7% below its estimated GF Value™ of $15.57.

Key valuation signals for MNICF:

  • Stock Based Compensation: $0.0 Mil
  • GF Value™: $15.57 vs. price of $12.82 (17.7% below fair value)
  • GF Score™: 97/100 with 7 warning signs

No single metric tells the full story. See the MNICF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mani Business Description

Other Exchanges 7730:Japan
Address 8-3 Kogyodanchi, Tochigi, JPN
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
97GF Score

Get the complete analysis for MNICF

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.82
Price
$15.57
GF Value